Wednesday, March 6, 2019

Postbiopsy pigmentation is prognostic in head and neck melanoma


Conference name: 2nd International conference on pathology
Short name: Pathology 2019
Venue : Paris,France| July 5-6,2019
URL:: https://bit.ly/2GS09CI


Researchers examined the prognostic value of postbiopsy pigmentation (PBP) in patients with cutaneous head and neck (H&N) melanoma. Three hundred patients who were undergoing sentinel lymph node biopsy (SLNB) for H&N melanoma (1998–2018) were retrospectively reviewed. They defined PBP as a visible remaining pigment at the scar or biopsy site that was documented on physical exam by both a medical oncologist and a surgeon at initial consultation. PBP was noted in 34.3%  and microscopic residual disease was reported in 44.7% (n = 134) on final pathology after wide local excision. Significantly shorter disease-free survival was observed for H&N melanoma patients with PBP. Hence they recommend giving greater consideration to SLNB and closer postoperative surveillance in patients with PBP.


Author:King BBT

To know more about Pathology and its Applications do attend International Conference on Pathology 2019 http://pathology.alliedacademies.com/

Contact
KRISTIE NOVA
Program Director | PATHOLOGY 2019

Phone: (44) 20 3769 1755
Email: 
pathology@alliedannualsummit.com

No comments:

Post a Comment